Shuyang Human Immunoglobulin-Neural Expert Academic Conference

From July 7 to 9, 2023, the first Shuyang Human Immunoglobulin-Neural Expert Academic Conference "2023 Human Immunoglobulin Neuroimmune Expert Advisory Meeting" was successfully held in Chengdu. With the purpose of exploring the future research direction of human immunoglobulin and promoting the rational and standardized drug use in clinical practice, the meeting carried out wonderful academic content sharing and panel discussions. During the meeting, the experts jointly discussed the differences in the application of human immunoglobulin between China and foreign countries, and offered suggestions for the academic promotion of human immunoglobulin.

At the beginning of the conference, Professor Dong Huiqing, the chairman of the conference, and Feng Zenghui, chairman of Grand Life Sciences Group, delivered speeches respectively. Professor Dong welcomed all the guests attending the conference, and thanked Shuyang for the academic platform, and hoped to have more cooperation with Shuyang in the future. Chairman Feng introduced the company's development history and future development plan, and at the same time expressed Shuyang's willingness to continue exploring in the field of neuroimmunology. Then Fu Zhengming, deputy general manager of Shuyang Marketing Center, introduced the company, focusing on the history of Shuyang, the establishment of the new factory and the advantages of human immunoglobulin.

In the topic sharing session, Professor Lu Zuneng from People's Hospital of Wuhan University shared the first topic "Overview of the Application of IVIG in Neuroimmune Diseases", focusing on the application value of human immunoglobulin in the entire neuroimmune field. In the second topic, Professor Huang Tianwen from Fujian Medical University Union Hospital shared "Current Status of Diagnosis and Treatment of CIDP and Exploration of IVIG Opportunities", focusing on the current status of diagnosis and treatment of CIDP, the evidence-based basis and existing research of human immunoglobulin in CIDP.

Through this expert advisory meeting, Shuyang Company completed the national-level expert network construction in the field of neuroimmunology, which opened a good start for further deepening the field of neurology. The meeting preliminarily clarified the current and future pattern of human immunoglobulin in neuroimmunology, and provided ideas for Shuyang product layout.